Market Cap 37.95B
Revenue (ttm) 19.67B
Net Income (ttm) 1.99B
EPS (ttm) N/A
PE Ratio 18.29
Forward PE 18.36
Profit Margin 10.13%
Debt to Equity Ratio 1.18
Volume 806,900
Avg Vol 3,663,678
Day's Range N/A - N/A
Shares Out 455.52M
Stochastic %K 39%
Beta 1.10
Analysts Strong Sell
Price Target $89.95

Company Profile

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning,...

Industry: Health Information Services
Sector: Healthcare
Phone: 833 735 1139
Address:
500 West Monroe Street, Chicago, United States
BooleanBets
BooleanBets Dec. 25 at 5:10 AM
$GEHC Strategic optionality narrows unless management’s ability to convert scale into defensible margin expansion, with outcomes shaped by timing and discipline. Operational proof points remain decisive.
0 · Reply
JasonCO
JasonCO Dec. 24 at 7:57 PM
0 · Reply
Thtguyukno
Thtguyukno Dec. 22 at 10:58 PM
$GEHC the only laggard of the fam.
0 · Reply
JustTradingHoy
JustTradingHoy Dec. 22 at 10:15 PM
$GEHC it see $80 that needs to hold and bounce. Otherwise back to low $70S Same story for two years
0 · Reply
QuantumChallah
QuantumChallah Dec. 20 at 4:33 PM
$BEAT combining the ambulance business which could result in $250 price alone in a few years, this has a potential of $380-$500 in 3-5 years on a fully 3x diluted shares But what is working behind the scene now is to convince the founder to dilute the shares at an agreed price purchased by a big partnership. This wouldn't affect but benefit the current shareholders, however the percentage of shares by the founder will be diluted. This is the possible reason of delayed news on dilutions. The founder insisted on $15 for a smaller percentage of shares to be sold to the partnership, or $26 sold at a higher percentage of shares. I ain't know things. So let's don't assume a hostile bid war when GE Healthcare $GEHC is upset to drive out Samsung and Apple people. Just saying, WO
2 · Reply
1iquid
1iquid Dec. 20 at 2:44 PM
OptionWizards Tip (education only): When trading options on FIX, GEHC, or STT, monitor bid-ask spreads to help avoid unnecessary entry and exit costs. $FIX $GEHC $STT Not financial advice.
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 19 at 3:43 PM
Actionable Trade Alert for $GEHC: Market Context: $GEHC is currently trading at $82.52, showing a stable position above the 30-day moving average (MA30) of $78.78 and the 50-day moving average (MA50) of $77.32. The RSI at 56.45 indicates a neutral to slightly bullish momentum, suggesting potential for upward movement. Directional Bias: The price is closer to the 60-day high of $86.19, indicating bullish sentiment. The distance from the 60-day low of $69.79 also supports the upward bias. Trade Plan: - Suggested Entry: $82.52 - Stop Loss: $80.37 (1 ATR below the entry) - Take Profit Targets: 1. $85.00 (3% gain) 2. $87.50 (6.5% gain) 3. $96.70 (17% gain) The third target aligns with the bullish trend and provides a solid risk-reward ratio. Monitor price action closely for any adjustments. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
ZacksResearch
ZacksResearch Dec. 17 at 5:29 PM
$GEHC partners with Indonesia on massive healthcare initiative — big move for emerging markets! 🌍 🤝 Over 300 CT scanners to boost care for 280M people 🌐 Multi-year contract through a global tender process 📈 Shares up 14.4% in 6 months vs. industry’s 1.2% decline, while S&P 500 gained 16.6% Discover the full impact here 👉 https://www.zacks.com/stock/news/2805793/gehc-expands-healthcare-access-through-indonesia-moh-partnership-deal?cid=sm-stocktwits-2-2805793-body-25255&ADID=SYND_STOCKTWITS_TWEET_2_2805793_BODY_25255
0 · Reply
ZacksResearch
ZacksResearch Dec. 17 at 4:29 PM
Big move for $GEHC in emerging markets — and it’s about access, not hype 🏥🌏 GE HealthCare is partnering with Indonesia’s Health Ministry under SIHREN to deploy CT scanners nationwide, expanding diagnostic capabilities across public hospitals. See how this partnership broadens GEHC’s global healthcare footprint 👉 https://www.zacks.com/stock/news/2805793/gehc-expands-healthcare-access-through-indonesia-moh-partnership-deal?cid=sm-stocktwits-2-2805793-teaser-25220&ADID=SYND_STOCKTWITS_TWEET_2_2805793_TEASER_25220
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 17 at 2:31 AM
Actionable Trade Alert for $GEHC: Market Context: $GEHC is currently trading at $82.45, showing bullish momentum as indicated by an RSI of 56.09, which is above the neutral level of 50. The stock is also above its 30-day (MA30) and 50-day (MA50) moving averages, signaling a positive trend. Directional Bias: The stock's current price is closer to its 60-day high of $86.19 than its low of $69.79, suggesting upward potential. The ATR of 2.15 indicates moderate volatility, providing room for price movement. Trade Plan: - Suggested Entry: $82.50 - Stop Loss: $79.00 (3.03% below entry) - Take Profit Targets: 1. $84.50 (2.43% gain) 2. $86.00 (4.48% gain) 3. $96.50 (17% gain) This plan offers a solid risk-reward ratio, with a potential 17% ROI on the third target. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
Latest News on GEHC
GE HealthCare to Acquire Intelerad for $2.3 Billion

Nov 20, 2025, 5:43 PM EST - 4 weeks ago

GE HealthCare to Acquire Intelerad for $2.3 Billion


GE Healthcare to acquire Intelerad for $2.3 billion

Nov 20, 2025, 4:12 PM EST - 4 weeks ago

GE Healthcare to acquire Intelerad for $2.3 billion


Tariffs Bite Into GE HealthCare Q3 Profit Margin

Oct 29, 2025, 11:42 AM EDT - 2 months ago

Tariffs Bite Into GE HealthCare Q3 Profit Margin


GE HealthCare Tech Profit Slides as Tariffs Drag

Oct 29, 2025, 7:33 AM EDT - 2 months ago

GE HealthCare Tech Profit Slides as Tariffs Drag


GE HealthCare reports third quarter 2025 financial results

Oct 29, 2025, 6:20 AM EDT - 2 months ago

GE HealthCare reports third quarter 2025 financial results


GE HealthCare announces cash dividend for third quarter of 2025

Sep 24, 2025, 3:58 PM EDT - 3 months ago

GE HealthCare announces cash dividend for third quarter of 2025


GE Healthcare exploring sale of China unit, source says

Sep 19, 2025, 2:20 AM EDT - 3 months ago

GE Healthcare exploring sale of China unit, source says


GE HealthCare: This Drop Represents A Buying Opportunity

Jul 31, 2025, 3:48 AM EDT - 5 months ago

GE HealthCare: This Drop Represents A Buying Opportunity


GE HealthCare reports second quarter 2025 financial results

Jul 30, 2025, 6:20 AM EDT - 5 months ago

GE HealthCare reports second quarter 2025 financial results


GE HealthCare Stock: Hidden Winner Of Alzheimer's Drug Boom

Jul 21, 2025, 2:08 PM EDT - 5 months ago

GE HealthCare Stock: Hidden Winner Of Alzheimer's Drug Boom


BooleanBets
BooleanBets Dec. 25 at 5:10 AM
$GEHC Strategic optionality narrows unless management’s ability to convert scale into defensible margin expansion, with outcomes shaped by timing and discipline. Operational proof points remain decisive.
0 · Reply
JasonCO
JasonCO Dec. 24 at 7:57 PM
0 · Reply
Thtguyukno
Thtguyukno Dec. 22 at 10:58 PM
$GEHC the only laggard of the fam.
0 · Reply
JustTradingHoy
JustTradingHoy Dec. 22 at 10:15 PM
$GEHC it see $80 that needs to hold and bounce. Otherwise back to low $70S Same story for two years
0 · Reply
QuantumChallah
QuantumChallah Dec. 20 at 4:33 PM
$BEAT combining the ambulance business which could result in $250 price alone in a few years, this has a potential of $380-$500 in 3-5 years on a fully 3x diluted shares But what is working behind the scene now is to convince the founder to dilute the shares at an agreed price purchased by a big partnership. This wouldn't affect but benefit the current shareholders, however the percentage of shares by the founder will be diluted. This is the possible reason of delayed news on dilutions. The founder insisted on $15 for a smaller percentage of shares to be sold to the partnership, or $26 sold at a higher percentage of shares. I ain't know things. So let's don't assume a hostile bid war when GE Healthcare $GEHC is upset to drive out Samsung and Apple people. Just saying, WO
2 · Reply
1iquid
1iquid Dec. 20 at 2:44 PM
OptionWizards Tip (education only): When trading options on FIX, GEHC, or STT, monitor bid-ask spreads to help avoid unnecessary entry and exit costs. $FIX $GEHC $STT Not financial advice.
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 19 at 3:43 PM
Actionable Trade Alert for $GEHC: Market Context: $GEHC is currently trading at $82.52, showing a stable position above the 30-day moving average (MA30) of $78.78 and the 50-day moving average (MA50) of $77.32. The RSI at 56.45 indicates a neutral to slightly bullish momentum, suggesting potential for upward movement. Directional Bias: The price is closer to the 60-day high of $86.19, indicating bullish sentiment. The distance from the 60-day low of $69.79 also supports the upward bias. Trade Plan: - Suggested Entry: $82.52 - Stop Loss: $80.37 (1 ATR below the entry) - Take Profit Targets: 1. $85.00 (3% gain) 2. $87.50 (6.5% gain) 3. $96.70 (17% gain) The third target aligns with the bullish trend and provides a solid risk-reward ratio. Monitor price action closely for any adjustments. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
ZacksResearch
ZacksResearch Dec. 17 at 5:29 PM
$GEHC partners with Indonesia on massive healthcare initiative — big move for emerging markets! 🌍 🤝 Over 300 CT scanners to boost care for 280M people 🌐 Multi-year contract through a global tender process 📈 Shares up 14.4% in 6 months vs. industry’s 1.2% decline, while S&P 500 gained 16.6% Discover the full impact here 👉 https://www.zacks.com/stock/news/2805793/gehc-expands-healthcare-access-through-indonesia-moh-partnership-deal?cid=sm-stocktwits-2-2805793-body-25255&ADID=SYND_STOCKTWITS_TWEET_2_2805793_BODY_25255
0 · Reply
ZacksResearch
ZacksResearch Dec. 17 at 4:29 PM
Big move for $GEHC in emerging markets — and it’s about access, not hype 🏥🌏 GE HealthCare is partnering with Indonesia’s Health Ministry under SIHREN to deploy CT scanners nationwide, expanding diagnostic capabilities across public hospitals. See how this partnership broadens GEHC’s global healthcare footprint 👉 https://www.zacks.com/stock/news/2805793/gehc-expands-healthcare-access-through-indonesia-moh-partnership-deal?cid=sm-stocktwits-2-2805793-teaser-25220&ADID=SYND_STOCKTWITS_TWEET_2_2805793_TEASER_25220
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 17 at 2:31 AM
Actionable Trade Alert for $GEHC: Market Context: $GEHC is currently trading at $82.45, showing bullish momentum as indicated by an RSI of 56.09, which is above the neutral level of 50. The stock is also above its 30-day (MA30) and 50-day (MA50) moving averages, signaling a positive trend. Directional Bias: The stock's current price is closer to its 60-day high of $86.19 than its low of $69.79, suggesting upward potential. The ATR of 2.15 indicates moderate volatility, providing room for price movement. Trade Plan: - Suggested Entry: $82.50 - Stop Loss: $79.00 (3.03% below entry) - Take Profit Targets: 1. $84.50 (2.43% gain) 2. $86.00 (4.48% gain) 3. $96.50 (17% gain) This plan offers a solid risk-reward ratio, with a potential 17% ROI on the third target. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
Arunas1
Arunas1 Dec. 16 at 11:47 PM
$UNH $XLV $GEHC Tariffs coming for Healthcare Insurance next 1-2 weeks. Will be Damming and Damaging Inseance Industry $DIA
1 · Reply
ScreamLikeABaby
ScreamLikeABaby Dec. 16 at 2:25 PM
$SYK $TEM $GEHC Tempus has a projected earnings growth rate of 58.9% for 2025, higher than the industry’s 37% growth. The company has a favorable current cashflow rate of 267.2% against the industry’s 28.3%. TEM has a projected sales growth rate of 82.2% (for the current fiscal year) compared with the industry’s 3.6% growth
0 · Reply
ZacksResearch
ZacksResearch Dec. 16 at 1:38 PM
AI Revolution in MedTech: What It Means for $SYK, $TEM & $GEHC 🚀 AI is transforming MedTech, from R&D to diagnostics, with startups and giants like Stryker, Tempus AI, and GE HealthCare leading the charge. These companies are leveraging AI for smarter operations, enhanced diagnostics, and improved patient care, setting the stage for future growth. Discover what makes these players stand out in the AI-driven MedTech landscape https://www.zacks.com/stock/news/2804794/3-medtech-stocks-poised-to-gain-in-2026-from-the-ai-boom?cid=sm-stocktwits-2-2804794-body-24930&ADID=SYND_STOCKTWITS_TWEET_2_2804794_BODY_24930
0 · Reply
ZacksResearch
ZacksResearch Dec. 16 at 12:38 PM
AI is coming for MedTech — and these 3 names could be the 2026 winners 🚀 AI is reshaping MedTech, with $SYK, $TEM, and $GEHC emerging as key players applying AI across surgery, diagnostics, and imaging—the core of modern healthcare innovation. Want to see how the AI boom could fuel gains into 2026? Full breakdown here 👉 https://www.zacks.com/stock/news/2804794/3-medtech-stocks-poised-to-gain-in-2026-from-the-ai-boom?cid=sm-stocktwits-2-2804794-teaser-24929&ADID=SYND_STOCKTWITS_TWEET_2_2804794_TEASER_24929
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 15 at 6:04 AM
Actionable Trade Alert for $GEHC: Market Context: $GEHC closed at $83.96, showing strong momentum. The RSI at 67.49 indicates it is approaching overbought territory, suggesting caution. However, the stock is above its 30-day (77.7) and 50-day (76.74) moving averages, indicating bullish sentiment. Directional Bias: The stock is trading near the 60-day high of 86.19, which could act as a resistance level. Given the current price action and moving averages, we maintain a bullish bias but watch for signs of reversal. Trade Plan: - Suggested Entry: $84.50 (slightly above the close to confirm upward momentum) - Stop Loss: $81.50 (risking $3.00, approximately 3.6%) - Take Profit Targets: 1. $87.00 (2.5% gain) 2. $89.00 (5.9% gain) 3. $98.00 (17% gain) This plan allows for a solid risk-reward ratio, with the potential for significant upside. Monitor the trade closely for any changes in momentum. https://privateprofiteers.com
0 · Reply
parcha
parcha Dec. 14 at 12:16 PM
$GEHC For GE HealthCare Technologies, the latest twelve month Free Cash Flow stands at about $1.43 billion. Analysts and extrapolated estimates suggest this could rise steadily over the coming decade, reaching roughly $4.59 billion by 2035, with intermediate projections like around $2.84 billion by 2028. When all those projected cash flows are discounted back, the model arrives at an intrinsic value of about $139.81 per share. Versus the recent share price near $86, the DCF points to the stock trading at roughly a 38.5% discount, which suggests potential upside if the cash flow path plays out as expected. Result: UNDERVALUED Our Discounted Cash Flow (DCF) analysis suggests GE HealthCare Technologies is undervalued by 38.5%. https://finance.yahoo.com/news/ge-healthcare-still-attractive-recent-180749446.html
0 · Reply
topstockalerts
topstockalerts Dec. 12 at 8:53 PM
GE split into three companies in 2021, rewarding long-term investors with gains of over 600% for those holding all spinoffs, far outperforming the S&P 500, Bitcoin, and Nvidia. GE HealthCare , initially expected to grow fastest, has lagged with 42% returns due to trade tensions, cautious hospital spending, and lower profit margins. GE Aerospace , retaining jet engine and related businesses, has outperformed with strong sales, margins, and a multiyear backlog driven by global air traffic growth. GE Vernova , formerly Renewable Energy & Power, was underestimated. Its large, profitable gas turbines and rising demand—partly fueled by AI-driven electricity needs—have boosted shares roughly 400% since the spinoff. Analysts cite broad electrification of U.S. buildings and data centers as key drivers of sustained electricity demand growth. $NVDA $GEHC $GEV $GE $DIS
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 11 at 10:57 PM
Actionable Trade Alert for $GEHC: Market Context: $GEHC is currently trading at $85.77, near its 60-day high of $85.89, indicating strong upward momentum. The RSI of 76.49 suggests the stock is overbought, which may lead to a pullback. However, the stock remains in a bullish trend given its position above both the 30-day MA (77.4) and the 50-day MA (76.59). Directional Bias: The bullish sentiment is supported by the recent price action, but caution is warranted due to the high RSI level. A potential pullback could create a buying opportunity. Trade Plan: - Suggested Entry: $85.50 - Stop Loss: $83.00 (risking $2.50) - Take Profit Targets: 1. $88.00 (Target 1: 2.5% ROI) 2. $90.00 (Target 2: 5.2% ROI) 3. $100.00 (Target 3: 16.5% ROI) This plan offers a favorable risk-reward profile with a potential ROI exceeding 17% on the third target. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
JarvisFlow
JarvisFlow Dec. 11 at 9:02 PM
Citigroup has adjusted their stance on GE HealthCare Techs ( $GEHC ), setting the rating to Neutral with a target price of 83 → 88.
0 · Reply
JarvisFlow
JarvisFlow Dec. 11 at 8:49 PM
Jefferies has adjusted their stance on GE HealthCare Techs ( $GEHC ), setting the rating to Buy with a target price of 95 → 105.
0 · Reply
Hshshhssos
Hshshhssos Dec. 10 at 5:56 PM
$GE $GEV $GEHC $WAB I cant think of a better example of value creation from a spinoff.
1 · Reply
stockanalysis_
stockanalysis_ Dec. 10 at 3:01 PM
Market Bullets: GE Vernova soars on U.S. pact, JPMorgan slumps nearly 5%, Palantir nets Navy contract. $GEHC $JPM $PLTR View the newsletter here: https://stockanalysis.com/market-bullets/2025-12-10/?ref=saveontrading
0 · Reply